Qianhao Zhao

Dr. Qianhao Zhao

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2018 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
MZMengyun Zhang
Mengyun Zhang
YDYong Dong
Yong Dong
FHFangxiao Hu
Fangxiao Hu
DYDan Yang
Dan Yang
QZQianhao Zhao
Qianhao Zhao
JWJinyong Wang
Jinyong Wang

28 July 2018 in International journal of legal medicine
Verified
Journal Article
Closed access
PDF file
JZJinxiang Zheng
Jinxiang Zheng
JGJian Guo
Jian Guo
LHLei Huang
Lei Huang
QWQiuping Wu
Qiuping Wu
KYKun Yin
Kun Yin
CJCheng Jianding
Cheng Jianding

3 October 2023 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
JZJingjing Zheng
Jingjing Zheng
LPLongyun Peng
Longyun Peng
RCRuofei Cheng
Ruofei Cheng
ZLZhiyan Li
Zhiyan Li
JXJianjie Xie
Jianjie Xie
QZQianhao Zhao
Qianhao Zhao
Background: Hypertrophic cardiomyopathy (HCM) is predominantly caused by mutations in sarcomeric genes. However, a subset of cases is attributed to genetic disorders unrelated to sarcomeric genes, such as Noonan syndrome (NS) and other RASopathies. In this study, we present a family with a history of sudden cardiac death (SCD) and focus on two adults with syndromic left ventricular hypertrophy (LVH).Methods: Clinical evaluations, including echocardiography, were conducted to assess cardiac manifestations. Whole‐exome sequencing was performed to identify potential genetic variants underlying syndromic LVH in the study participants.Results: Whole‐exome sequencing revealed a missense variant in the RAF1 gene, c.782C>T (p.Pro261Leu). This variant confirmed the diagnosis of NS in the affected individuals.Conclusion: The findings of this study underscore the importance of family history investigation and genetic testing in diagnosing syndromic LVH. By identifying the underlying genetic cause, clinicians can better understand the etiology of RAS‐HCM and its association with SCD in young adults.

18 June 2018 in Nature Immunology
Verified
Journal Article
Open access
PDF file
MZMengyun Zhang
Mengyun Zhang
YDYong Dong
Yong Dong
FHFangxiao Hu
Fangxiao Hu
DYDan Yang
Dan Yang
QZQianhao Zhao
Qianhao Zhao
JWJinyong Wang
Jinyong Wang
In the version of this article initially published, some identification of the supplementary information was incorrect. The items originally called Supplementary Tables 1, 2, 3, 4 and 5 should be Source Data Figures 1, 2, 4, 5 and 7, respectively; those originally called Supplementary Tables 6, 7 and 8 should be Supplementary Tables 1, 2 and 3, respectively; and those originally called Source Data Figures 1, 2, 4, 5 and 7 should be Supplementary Tables 4, 5, 6, 7 and 8, respectively. The errors have been corrected in the HTML version of the article.

1 February 2024 in Stem Cell Research
Verified
Journal Article
Open access
QZQianhao Zhao
Qianhao Zhao
MZMengyun Zhang
Mengyun Zhang
XLXiaofei Liu
Xiaofei Liu
TWTongjie Wang
Tongjie Wang
CXChengxiang Xia
Chengxiang Xia
CJCheng Jianding
Cheng Jianding
Hoxb5 exhibits preferential expression in hematopoietic stem cells (HSCs) and uniquely marks the long-term HSCs (LT-HSCs). Previous studies have demonstrated the remarkable capability of Hoxb5 to alter cell fates when enforced expression in blood progenitors, such as B cell progenitors and multipotent progenitors. Additionally, Hoxb5 deficiency does not hinder the generation of LT-HSCs. However, the specific impact of Hoxb5 deletion on LT-HSCs has remained unexplored. To address this, we developed a conditional Hoxb5 knockout-reporter mouse model, wherein Hoxb5 was knock out by the Vav-cre recombinase, and the endogenous Hoxb5 promoter drove the expression of the blue fluorescent protein (BFP). Our findings revealed that the primary recipients, who transplanted with HSCs indicating Hoxb5 deficiency by the presence of BFP (BFP-positive HSCs), exhibited comparable levels of donor chimerism and lineage chimerism to recipients transplanted with HSCs that spontaneously did not express Hoxb5 and thus lacked BFP expression (BFP-negative HSCs). However, during the secondary transplantation, recipients receiving total bone marrow (BM) from the primary recipients with BFP-positive HSCs showed significantly higher levels of donor chimerism and more robust multi-lineage chimerism compared to those receiving total BM from the primary recipients with BFP-negative HSCs. Our results indicate that deleting Hoxb5 in LT-HSCs transiently influences their lineage differentiation bias without compromising their long-term self-renewal capacity. These findings highlight the primary role of Hoxb5 in regulating lineage commitment decisions in LT-HSCs, while emphasizing that its presence is not indispensable for the maintenance of long-term self-renewal capacity.

12 August 2024 in Forensic Science, Medicine and Pathology
Verified
Journal Article
Closed access
PDF file
RLRui Li
Rui Li
DZDa Zheng
Da Zheng
CLChunxi Lin
Chunxi Lin
YCYili Chen
Yili Chen
YBYang Bai
Yang Bai
EHErwen Huang
Erwen Huang